A BuiltForAI Property
Drug class profile · refreshed daily from federal data

Polyene Antifungal

6 molecules in this class, $116.2M combined CY2024 Part D spend across 6.0M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the Polyene Antifungal class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class
6tracked in Part D
CY24 Part D spend
$116.2Mcombined across class
Total Rx claims
6.0M3.4M unique beneficiaries
Generic mfrs (active)
37across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard
01
Nystatin
Brand: Mycostatin · 6.0M Part D claims (CY24) · 3.4M beneficiaries · First FDA approval:
24 generic mfrs 0 plans require PA Discontinued
Low NADAC$0.065
Avg plan cost$0.264
Part D spend $116.2M spread, current vs floor
Class share
100%
of class CY24 spend
View profile →
02
Nystatin Cream
Brand: Nystatin · Part D claims (CY24) · First FDA approval:
Brand-only (no generics)
Low NADAC$0.155
Avg plan cost$0.178
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →
03
Nystatin Ointment
Brand: Nystatin · Part D claims (CY24) · First FDA approval:
Brand-only (no generics)
Low NADAC$0.248
Avg plan cost$0.252
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →
04
Nystatin Topical Powder
Brand: KLAYESTA · Part D claims (CY24) · First FDA approval:
Brand-only (no generics)
Low NADAC$0.275
Avg plan cost$0.344
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →
05
Nystatin and Triamcinolone Acetonide
Part D claims (CY24) · First FDA approval:
Brand-only (no generics) 0 plans require PA
Low NADAC$0.208
Avg plan cost$0.261
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →
06
Nystatin, Triamcinolone Acetonide
Brand: NYSTATIN AND TRIAMCINOLONE ACETONIDE · Part D claims (CY24) · First FDA approval:
13 generic mfrs
Low NADAC$0.208
Avg plan cost$0.244
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →